This page is intended for members of the media profession
UK Government Announces Covid-19 Vaccination Contract Extension with Wockhardt
Wockhardt, the global pharmaceutical and biotechnology major today announced that it has been awarded a six-month extension of its agreement with the UK Government to fill-finish COVID-19 vaccines. This expands the original agreement from…
Wockhardt hosts visit of the UK Prime Minister
Wockhardt, the global pharmaceutical and biotechnology major, today hosted a visit at its Wrexham facility in North Wales of the Prime Minister of the United Kingdom, Mr Boris Johnson.
The Prime Minister inspected Wockhardt’s fill finish…
Wockhardt UK’s Amoxicillin Sodium 250mg, 500mg and 1g Powder for Solution for Injection
Wockhardt UK, in agreement with MHRA, would like to inform you of the following:
Summary
In 2014, a Class 4 Drug Alert asked healthcare professionals not to use Wockhardt UK’s Amoxicillin Sodium Powder for Solution for Injection (all…
Wockhardt announces COVID-19 vaccine partnership with UK Government
Wockhardt announces COVID-19 vaccine partnership with UK Government Wockhardt, the global pharmaceutical and biotechnology major today announced that it has entered
into an agreement with the UK Government to fill finish COVID-19 vaccines.…
Wockhardt UK Launches Clobazam Oral Suspension 5mg/5ml, 10mg/5ml (150ml)
Wockhardt UK launch Clobazam Oral Suspension 5mg/5ml, 10mg/5ml (150ml)
Wockhardt UK Launches Clobazam Oral Suspension 5mg/5ml, 10mg/5ml (150ml) adding to our extensive range of oral solutions and suspensions. Developed in housed by our owan…